NCT00045500View on ClinicalTrials.gov

UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Primary Completion Date

January 31, 2010

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

7-hydroxystaurosporine

DRUG

prednisone

Trial Locations (3)

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

21702-1201

Frederick Cancer Research and Development Center, Frederick

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00045500 - UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter